Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
Karolinska University Hospital · Karolinska Institutet · +13 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
2,259
total citations
- FWCI
- 51.56
- Percentile
- 100%
- References
- 68
Citations per year
Authors
18- VMVanessa Monteil
Karolinska University Hospital, Karolinska Institutet
- HKHyesoo Kwon
Swedish Veterinary Agency
- PPPatricia Prado
Institute for Bioengineering of Catalonia
- AHAstrid Hagelkrüys
Institute of Molecular Biotechnology, Austrian Academy of Sciences
- RWReiner Wimmer
Institute of Molecular Biotechnology, Austrian Academy of Sciences
Topics & keywords
Keywords
- Biology
- Vero cell
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Virology
- Angiotensin-converting enzyme 2
- Coronavirus
- Recombinant DNA
- Receptor
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.